Suppr超能文献

Conflicts of interest, authorship, and disclosures in industry-related scientific publications.

作者信息

Fonseca Rafael, Richardson Paul, Giralt Sergio, Lonial Sagar, Rajkumar S Vincent, Stewart A Keith, Bensinger William, Somlo George, Vescio Robert, Mikhael Joseph, Reeder Craig, Tiedemann Rodger, Tricot Guido, Rifkin Robert, Shaughnessy John, Munshi Nikhil, Raje Noopur, Ghobrial Irene, Laubach Jacob, Schlossman Robert, Treon Steven, Mahindra Anuj, Avigan David, Rosenblatt Jacalyn, Jagannath Sundar, Niesvizky Ruben, Landau Heather, Chen-Kiang Selina, Siegel David S, Zimmerman Todd, Mehta Jayesh, Vesole David, Rosen Steven, Hofmeister Craig, Lacy Martha, Dispenzieri Angela, Borrello Ivan, Hayman Suzanne R, Kumar Shaji, Buadi Frances, Dingli David, Russell Stephen, Melissa Alsina Melissa Alsina, Fernandez Hugo, Roy Vivek, Pereira Denise, Stadtmauer Edward, Vij Ravi, Jakubowiak Andrzej, Lentzsch Suzanne, Song Kevin, Trudel Suzanne, Chen Christine, Reece Donna, Stewart Douglas, Singhal Seema, Comenzo Raymond, Gertz Morie A, Greipp Philip R, Durie Brian, Barlogie Bart, Anderson Kenneth, Dalton William, Coleman Morton, Novis Susie, Kyle Robert A

出版信息

Mayo Clin Proc. 2010 Feb;85(2):197-9; author reply 201-4. doi: 10.4065/mcp.2009.0559.

DOI:10.4065/mcp.2009.0559
PMID:20118399
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC2813833/
Abstract
摘要

相似文献

1
Conflicts of interest, authorship, and disclosures in industry-related scientific publications.与行业相关的科学出版物中的利益冲突、作者身份及披露情况
Mayo Clin Proc. 2010 Feb;85(2):197-9; author reply 201-4. doi: 10.4065/mcp.2009.0559.
2
Conflicts of interest, authorship, and disclosures in industry-related scientific publications.与行业相关的科学出版物中的利益冲突、作者身份及披露情况。
Mayo Clin Proc. 2010 Feb;85(2):196; author reply 201-4. doi: 10.4065/mcp.2009.0610.
3
Conflicts of interest, authorship, and disclosures in industry-related scientific publications.与行业相关的科学出版物中的利益冲突、作者身份及披露情况
Mayo Clin Proc. 2010 Feb;85(2):196-7; author 201-4. doi: 10.4065/mcp.2009.0616.
4
Conflicts of interest, authorship, and disclosures in industry-related scientific publications.与行业相关的科学出版物中的利益冲突、作者身份及披露情况。
Mayo Clin Proc. 2010 Feb;85(2):200-1. doi: 10.4065/mcp.2009.0595.
5
Conflicts of interest, authorship, and disclosures in industry-related scientific publications.与行业相关的科学出版物中的利益冲突、作者身份及披露情况。
Mayo Clin Proc. 2010 Feb;85(2):199; author reply 201-4. doi: 10.4065/mcp.2009.0553.
6
Conflicts of interest, authorship, and disclosures in industry-related scientific publications.与行业相关的科学出版物中的利益冲突、作者身份及披露情况。
Mayo Clin Proc. 2010 Feb;85(2):199-200; author reply 201-4. doi: 10.4065/mcp.2009.0744.
7
Conflicts of interest, authorship, and disclosures in industry-related scientific publications: the tort bar and editorial oversight of medical journals.与行业相关的科学出版物中的利益冲突、作者身份及信息披露：侵权律师与医学期刊的编辑监督
Mayo Clin Proc. 2009 Sep;84(9):811-21. doi: 10.4065/84.9.811.
8
Corporate versus public interests: community responsibility to defend scientific integrity.企业利益与公众利益：捍卫科学诚信的社会责任
Int J Occup Environ Health. 2011 Apr-Jun;17(2):181-5.
9
Ghostwriting in medical literature.医学文献中的代笔问题。
Int J Occup Environ Health. 2011 Apr-Jun;17(2):168-77.
10
Conflict of interest policies and disclosure requirements among European Society of Cardiology National Cardiovascular Journals.欧洲心脏病学会各国家心血管杂志的利益冲突政策及披露要求
Rev Esp Cardiol (Engl Ed). 2012 May;65(5):471-8. doi: 10.1016/j.recesp.2012.02.002. Epub 2012 Mar 30.

本文引用的文献

1
Pomalidomide (CC4047) plus low-dose dexamethasone as therapy for relapsed multiple myeloma.泊马度胺（CC4047）联合低剂量地塞米松治疗复发多发性骨髓瘤。
J Clin Oncol. 2009 Oct 20;27(30):5008-14. doi: 10.1200/JCO.2009.23.6802. Epub 2009 Aug 31.
2
Conflicts of interest, authorship, and disclosures in industry-related scientific publications: the tort bar and editorial oversight of medical journals.与行业相关的科学出版物中的利益冲突、作者身份及信息披露：侵权律师与医学期刊的编辑监督
Mayo Clin Proc. 2009 Sep;84(9):811-21. doi: 10.4065/84.9.811.
3
Bidirectional conflicts of interest involving industry and medical journals: who will champion integrity?涉及行业与医学期刊的双向利益冲突：谁将捍卫诚信？
Mayo Clin Proc. 2009 Sep;84(9):771-5. doi: 10.4065/84.9.771.
4
Improved survival of patients with multiple myeloma after the introduction of novel agents and the applicability of the International Staging System (ISS): an analysis of the Greek Myeloma Study Group (GMSG).新型药物引入后多发性骨髓瘤患者生存率的提高及国际分期系统（ISS）的适用性：希腊骨髓瘤研究组（GMSG）的分析
Leukemia. 2009 Jun;23(6):1152-7. doi: 10.1038/leu.2008.402. Epub 2009 Feb 19.
5
Bortezomib plus melphalan and prednisone for initial treatment of multiple myeloma.硼替佐米联合美法仑和泼尼松用于多发性骨髓瘤的初始治疗。
N Engl J Med. 2008 Aug 28;359(9):906-17. doi: 10.1056/NEJMoa0801479.
6
Lenalidomide plus dexamethasone for relapsed multiple myeloma in North America.来那度胺联合地塞米松治疗北美复发多发性骨髓瘤
N Engl J Med. 2007 Nov 22;357(21):2133-42. doi: 10.1056/NEJMoa070596.
7
Lenalidomide plus dexamethasone for relapsed or refractory multiple myeloma.来那度胺联合地塞米松治疗复发或难治性多发性骨髓瘤。
N Engl J Med. 2007 Nov 22;357(21):2123-32. doi: 10.1056/NEJMoa070594.
8
Improved survival in multiple myeloma and the impact of novel therapies.多发性骨髓瘤患者生存率的提高及新型疗法的影响
Blood. 2008 Mar 1;111(5):2516-20. doi: 10.1182/blood-2007-10-116129. Epub 2007 Nov 1.
9
Divergent views on managing clinical conflicts of interest.关于管理临床利益冲突的不同观点。
Mayo Clin Proc. 2007 Aug;82(8):1013-4; author reply 1014-5. doi: 10.4065/82.8.1013.
10
Regulating academic-industrial research relationships--solving problems or stifling progress?规范学术-产业研究关系——是解决问题还是阻碍进步？
N Engl J Med. 2005 Sep 8;353(10):1060-5. doi: 10.1056/NEJMsb051758.

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验